sitimagene ceradenovec
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Glioblastoma multiforme (GBM) is associated with a poor prognosis with a 5-year survival rate of less than 5%, making GBM one of…
Ark Therapeutics Group plc is developing sitimagene ceradenovec, a herpes simplex virus thymidine kinase/ganciclovir gene therapy…